CELZ

Creative Medical Technology Holdings Inc develops stem cell-based therapies for medical conditions, including kidney disease and infertility. Hospitals and patients might use these treatments if approved, as they offer potential alternatives to traditional methods. The company makes money by advancing these therapies through clinical trials, seeking partnerships, and aiming for future sales if successful, which requires significant research investment.